Loading company
Latest annual · FY2025
Millions- Total revenues
- 43
- Operating income
- (215)
- Net income
- (204)
- Free cash flow
- (188)
Latest quarter · Q3 FY2026
Millions- Total revenues
- 13
- Operating income
- (66)
- Net income
- (62)
- Free cash flow
- (60)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2022 to FY2025
- +127.1%
- Revenue, 5 yearsFY2020 to FY2025
- +16.3%
- Net income, 5 yearsFY2020 to FY2025
- n/m
Wave Life Sciences, Inc. (WVE) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $42.7 million | $108.3 million | -60.5% | 10-K 2026-02-26 · proof |
| Operating income | -$215.4 million | -$110.4 million | 10-K 2026-02-26 · proof | |
| Net income | -$204.4 million | -$97 million | 10-K 2026-02-26 · proof | |
| Cash from operating activities | -$187.5 million | -$151 million | 10-K 2026-02-26 · proof | |
| Free cash flow | -$188.2 million | -$152 million | 10-K 2026-02-26 · proof | |
| Total assets | $638.5 million | $352.2 million | +81.3% | 10-K 2026-02-26 · proof |
| Total liabilities | $112.3 million | $134.8 million | -16.7% | 10-K 2026-02-26 · proof |
| Cash and cash equivalents | $602.1 million | $302.1 million | +99.3% | 10-K 2026-02-26 · proof |
- What was Wave Life Sciences, Inc. (WVE)'s revenue in fiscal 2025?
- Wave Life Sciences, Inc. (WVE) reported revenue of $42.7 million for fiscal 2025 (the year ended Dec 31, 2025), against $108.3 million the year before (-60.5%). Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
- What was Wave Life Sciences, Inc. (WVE)'s operating income in fiscal 2025?
- Wave Life Sciences, Inc. (WVE) reported operating income of -$215.4 million for fiscal 2025 (the year ended Dec 31, 2025), against -$110.4 million the year before. Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
- What was Wave Life Sciences, Inc. (WVE)'s net income in fiscal 2025?
- Wave Life Sciences, Inc. (WVE) reported net income of -$204.4 million for fiscal 2025 (the year ended Dec 31, 2025), against -$97 million the year before. Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
- What was Wave Life Sciences, Inc. (WVE)'s cash from operating activities in fiscal 2025?
- Wave Life Sciences, Inc. (WVE) reported cash from operating activities of -$187.5 million for fiscal 2025 (the year ended Dec 31, 2025), against -$151 million the year before. Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
- What was Wave Life Sciences, Inc. (WVE)'s free cash flow in fiscal 2025?
- Wave Life Sciences, Inc. (WVE) reported free cash flow of -$188.2 million for fiscal 2025 (the year ended Dec 31, 2025), against -$152 million the year before. Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
- What are Wave Life Sciences, Inc. (WVE)'s total assets?
- As of Dec 31, 2025, Wave Life Sciences, Inc. (WVE) reported total assets of $638.5 million, against $352.2 million a year earlier (+81.3%). Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
- What are Wave Life Sciences, Inc. (WVE)'s total liabilities?
- As of Dec 31, 2025, Wave Life Sciences, Inc. (WVE) reported total liabilities of $112.3 million, against $134.8 million a year earlier (-16.7%). Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
- What are Wave Life Sciences, Inc. (WVE)'s cash and cash equivalents?
- As of Dec 31, 2025, Wave Life Sciences, Inc. (WVE) reported cash and cash equivalents of $602.1 million, against $302.1 million a year earlier (+99.3%). Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:WVE&period_type=annual&limit=5"Information only, not investment advice.